MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41375-023-02129-y

Медицинская библиотека · Leukemia · 2024

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Fischer Luise, Grieb Nora, Born Patrick, Weiss Ronald, Seiffert Sabine, Boldt Andreas, Fricke Stephan, Franz Paul, Heyn Simone, Kubasch Anne Sophie, Baber Ronny, Weidner Heike, Wang Song Yau, Bach Enrica, Hoffmann Sandra, Ussmann Jule, Kirchberg Janine, Hell Saskia, Schwind Sebastian, Metzeler Klaus H, Herling Marco, Jentzsch Madlen, Franke Georg-Nikolaus, Sack Ulrich, Reiche Kristin, Köhl Ulrike, Platzbecker Uwe, Vucinic Vladan, Merz Maximilian

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T cells revolutionized the treatment of relapsed/refractory multiple myeloma (RRMM). However, data on cellular (CAR) T cell dynamics and the association with response, resistance or the occurrence of cytokine release syndrome (CRS) are limited. Therefore, we performed a comprehensive flow cytometry analysis of 27 RRMM patients treated with Idecabtagene vicleucel (Ide-cel) to assess the expansion capacity, persistence and effects on bystander cells of BCMA-targeting CAR T cells. Additionally, we addressed side effects, like cytokine release syndrome (CRS) and cytopenia. Our results show that in vivo expansion of CD8+ CAR T cells is correlated to response, however persistence is not essential for durable remission in RRMM patients. In addition, our data provide evidence, that an increased fraction of CD8+ T cells at day of leukapheresis in combination with successful lymphodepletion positively influence the outcome. We show that patients at risk for higher-grade CRS can be identified already prior to lymphodepletion. Our extensive characterization contributes to a better understanding of the dynamics and effects of BCMA-targeting CAR T cells, in order to predict the response of individual patients as well as side effects, which can be counteracted at an early stage or even prevented.

Для цитирования: Fischer Luise, Grieb Nora, Born Patrick, Weiss Ronald, Seiffert Sabine, Boldt Andreas, Fricke Stephan, Franz Paul, Heyn Simone, Kubasch Anne Sophie, Baber Ronny, Weidner Heike, Wang Song Yau, Bach Enrica, Hoffmann Sandra, Ussmann Jule, Kirchberg Janine, Hell Saskia, Schwind Sebastian, Metzeler Klaus H, Herling Marco, Jentzsch Madlen, Franke Georg-Nikolaus, Sack Ulrich, Reiche Kristin, Köhl Ulrike, Platzbecker Uwe, Vucinic Vladan, Merz Maximilian. Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.. Leukemia. 2024. DOI: 10.1038/s41375-023-02129-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.